Continuity has been a hallmark of the Acadia Healthcare story, and Reeve Waud embodies it. He helped found the company in 2005 and still chairs its board, a span of involvement few founders match. The January 2026 appointment of Debbie Osteen as chief executive carried that same theme forward.
Institutional knowledge tends to steady an organization. Acadia Healthcare’s recent moves lean on it hard.
A Founder Who Stayed Involved
Reeve Waud created Acadia Healthcare through Waud Capital Partners and never fully stepped back. He went from founding investor to board chairman and kept a hand in the company’s direction across two decades.
That kind of sustained involvement is unusual. A board chairman who founded the company brings a memory of its full history to every big decision.
A CEO Who Knows the Company
Osteen’s return follows the same logic. She led Acadia Healthcare from 2018 to 2022 and came back in 2026 to a role and an organization she already understood.
Reeve Waud framed her appointment as a deliberate choice and cited her “deep knowledge of Acadia and track record of success”. Pair a founder-chairman with a returning chief executive and Acadia Healthcare ends up with two leaders who know the company well, a combination built on familiarity rather than guesswork.